Literature DB >> 14594095

Ophthaproblem. Optic neuritis.

Jason Blair1, Sanjay Sharma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594095      PMCID: PMC2214134     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  6 in total

Review 1.  Evidence-based neuro-ophthalmology: advances in treatment.

Authors:  L J Balcer
Journal:  Curr Opin Ophthalmol       Date:  2001-12       Impact factor: 3.761

2.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

3.  What we have learned from the Optic Neuritis Treatment Trial.

Authors:  R W Beck; J D Trobe
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

4.  Recovery of visual field function in the optic neuritis treatment trial.

Authors:  J P Fang; R H Lin; S P Donahue
Journal:  Am J Ophthalmol       Date:  1999-11       Impact factor: 5.258

5.  Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study.

Authors:  J F Rizzo; S Lessell
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

Review 6.  Management of acute optic neuritis.

Authors:  S J Hickman; C M Dalton; D H Miller; G T Plant
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.